VASCULAR ANOMALY
Clinical trials for VASCULAR ANOMALY explained in plain language.
Never miss a new study
Get alerted when new VASCULAR ANOMALY trials appear
Sign up with your email to follow new studies for VASCULAR ANOMALY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare blood vessel disorders: targeted drugs enter trial
Disease control Recruiting nowThis study tests two targeted drugs (alpelisib and mirdametinib) in 50 people aged 2 and older with vascular malformations—abnormal blood or lymph vessels. Participants receive 48 weeks of treatment based on their genetic mutation type. The goal is to see if these drugs improve e…
Matched conditions: VASCULAR ANOMALY
Phase: PHASE2 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated May 17, 2026 08:55 UTC
-
New study tracks pregnancy dangers in rare vascular conditions
Knowledge-focused Recruiting nowThis study follows 400 pregnant women with rare blood vessel diseases (like hereditary hemorrhagic telangiectasia, Marfan syndrome, or arteriovenous malformations) to track serious complications for mother and baby. Researchers will collect data via phone questionnaires during pr…
Matched conditions: VASCULAR ANOMALY
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated May 07, 2026 18:41 UTC